Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Pavnit Kukreja"'
Autor:
Victor S.C. Fung, Jason Aldred, Martha P. Arroyo, Filip Bergquist, Agnita J.W. Boon, Manon Bouchard, Sarah Bray, Sara Dhanani, Maurizio F. Facheris, Nahome Fisseha, Eric Freire-Alvarez, Robert A. Hauser, Anna Jeong, Jia Jia, Pavnit Kukreja, Michael J. Soileau, Amy M. Spiegel, Saritha Talapala, Arjun Tarakad, Enrique Urrea-Mendoza, Jorge Zamudio, Rajesh Pahwa
Publikováno v:
Clinical Parkinsonism & Related Disorders, Vol 10, Iss , Pp 100239- (2024)
Background: As Parkinson's disease (PD) advances, management is challenged by an increasingly variable and inconsistent response to oral dopaminergic therapy, requiring special considerations by the provider. Continuous 24 h/day subcutaneous infusion
Externí odkaz:
https://doaj.org/article/ee4b4d82effb4c59b7e2610de99a7111
Autor:
James T. Boyd, Cindy Zadikoff, Janet A. Benesh, Jorge Zamudio, Weining Z. Robieson, Pavnit Kukreja, Masayuki Yokoyama, Mustafa S. Siddiqui
Publikováno v:
Clinical Parkinsonism & Related Disorders, Vol 2, Iss , Pp 25-34 (2020)
Introduction: As Parkinson's disease (PD) progresses, the number/frequency of PD medications tend to increase, which is correlated with decreased patient compliance and suboptimal control of PD symptoms. We investigated efficacy and safety of levodop
Externí odkaz:
https://doaj.org/article/0aaba9c46e2842f084599e752bb59234
Autor:
Cindy Zadikoff, Werner Poewe, James T. Boyd, Lars Bergmann, Horia Ijacu, Pavnit Kukreja, Weining Z. Robieson, Janet Benesh, Angelo Antonini
Publikováno v:
Parkinson's Disease, Vol 2020 (2020)
Background. Levodopa-carbidopa intestinal gel (LCIG) provides continuous levodopa administration and clinical benefits to patients with advanced Parkinson’s disease (PD). This report evaluates long-term safety and efficacy of high-dose LCIG in PD p
Externí odkaz:
https://doaj.org/article/6f50c99361074ba09bc15f85b7ceb9b9
Autor:
Drew Kern, Khashayar Dashtipour, Jason Aldred, Thomas Kimber, Robert Iansek, Pavnit Kukreja, Lars Bergmann, Nahome Fisseha, Resmi Gupta, Saritha Talapala, Anna Jeong, Victor Fung, Vincent Lepetit
Publikováno v:
Tuesday, April 25.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e58de2f731cf06f75b99cbc3a83713e6
https://doi.org/10.1212/wnl.0000000000201730
https://doi.org/10.1212/wnl.0000000000201730
Autor:
Alberto Espay, Pilar Sanchez Alonso, Ramsey Falconer, Carrie Ferguson, Kazuko Hasegawa, Meredith Hatcher, Pavnit Kukreja, Koray Onuk, Connie Yan, Jorge Zamudio, Victor Fung
Publikováno v:
Wednesday, April 26.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::72c79047032615434ff6d49e68b52080
https://doi.org/10.1212/wnl.0000000000203880
https://doi.org/10.1212/wnl.0000000000203880
Autor:
Per Odin, Rajesh Pahwa, Jill Farmer, Thomas Kimber, Bruno Bergmans, Eric Freire Alvarez, K Ray Chaudhuri, Resmi Gupta, Connie H. Yan, Lars Bergmann, Pavnit Kukreja, Angelo Antonini
Publikováno v:
Sunday, April 23.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c903b21630604c1f9840459971ba90e4
https://doi.org/10.1212/wnl.0000000000202205
https://doi.org/10.1212/wnl.0000000000202205
Autor:
Rajesh Pahwa, Jason Aldred, Niodita Gupta, Emi Terasawa, Viviana Garcia-Horton, David R. Steffen, Prasanna L. Kandukuri, Vivek S. Chaudhari, Yash J. Jalundhwala, Yanjun Bao, Pavnit Kukreja, Stuart H. Isaacson
Publikováno v:
Neurology and Therapy. 11:711-723
A clinical trial in advanced Parkinson's disease (APD) has established the superiority of carbidopa/levodopa enteral suspension (CLES) in reducing total patient "off" time (OFF) and increasing total "on" time without troublesome dyskinesia (ON-woTD)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a348567fe8616407ac790670e5c49c0
https://doi.org/10.1007/s40120-022-00332-0
https://doi.org/10.1007/s40120-022-00332-0
Autor:
Marieta Anca-Herschkovitsch, Weining Z. Robieson, Norbert Kovács, Jason Aldred, David G. Standaert, Lars Bergmann, K. Ray Chaudhuri, Pavnit Kukreja, Francesco E. Pontieri, Mihaela Simu, Esther Cubo, Thomas L. Davis, Robert Iansek, Mustafa S. Siddiqui, Paul Bourgeois
Publikováno v:
Movement Disorders Clinical Practice
Background Levodopa‐carbidopa intestinal gel (LCIG) is an established treatment for improving motor and some non‐motor symptoms (NMS) in patients with advanced Parkinson's disease (PD). Prospective long‐term data in routine clinical practice ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1e8ff42f30783003203c6ac2cc16ab3
https://doi.org/10.1002/mdc3.13239
https://doi.org/10.1002/mdc3.13239
Autor:
K. Ray Chaudhuri, Jason Aldred, Ali Alobaidi, Pavnit Kukreja, Yanjun Bao, Sushmitha Inguva, Rajesh Pahwa, Yash J. Jalundhwala, Angelo Antonini, Lars Bergmann, Per Odin
Publikováno v:
Advances in Therapy
Introduction Levodopa/carbidopa intestinal gel (LCIG; carbidopa/levodopa enteral suspension) has been widely used and studied for the treatment of motor fluctuations in levodopa-responsive patients with advanced Parkinson’s disease (PD) when other
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc7f6a39a9df022d4ddfeb779a8f32bc
https://doi.org/10.1007/s12325-021-01747-1
https://doi.org/10.1007/s12325-021-01747-1
Autor:
Weining Z. Robieson, Cindy Zadikoff, Pavnit Kukreja, Masayuki Yokoyama, James T. Boyd, Janet Benesh, Mustafa S. Siddiqui, Jorge Zamudio
Publikováno v:
Clinical Parkinsonism & Related Disorders, Vol 2, Iss, Pp 25-34 (2020)
Clinical Parkinsonism & Related Disorders
Clinical Parkinsonism & Related Disorders
Introduction As Parkinson's disease (PD) progresses, the number/frequency of PD medications tend to increase, which is correlated with decreased patient compliance and suboptimal control of PD symptoms. We investigated efficacy and safety of levodopa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42bfec09ef6c6b60317aec790cd111b2
https://doi.org/10.1016/j.prdoa.2019.12.001
https://doi.org/10.1016/j.prdoa.2019.12.001